ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,740Medicare Part D Prescriptions Filled, Including Refills

Rank: 121 out of 1383

$955K Total Retail Price of All Prescriptions

Rank: 69 out of 1383

753 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 753 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 753 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 13,233 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LEVOTHYROXINE SODIUM 668 582 1 4
LISINOPRIL 514 426 2 3
SIMVASTATIN 470 389 3 2
FUROSEMIDE 415 381 4 7
METFORMIN HCL 407 323 5 8
OMEPRAZOLE 357 299 6 5
HYDROCHLOROTHIAZIDE 357 285 6 10
POTASSIUM CHLORIDE 325 300 8 12
HYDROCODONE-ACETAMINOPHEN 311 243 S3 9 1
CITALOPRAM HBR 301 245 10 15
AMLODIPINE BESYLATE 283 278 11 6
ATENOLOL 260 214 12 16
METOPROLOL TARTRATE 259 232 13 9
WARFARIN SODIUM 207 175 14 13
TAMSULOSIN HCL 188 151 15 30
GABAPENTIN 184 155 16 11
PRAVASTATIN SODIUM 170 145 17 14
ATORVASTATIN CALCIUM 168 142 18 18
NAMENDA 167 167 19 49
RANITIDINE HCL 161 139 20 19
LOVASTATIN 159 121 21 22
DONEPEZIL HCL 156 156 22 35
ZOLPIDEM TARTRATE 156 119 22 17
NEXIUM 150 109 24 26
CLOPIDOGREL 146 128 25 28
MELOXICAM 134 105 26 20
SINGULAIR 121 95 27 82
PANTOPRAZOLE SODIUM 119 94 28 32
TRAMADOL HCL 117 90 29 25
LOSARTAN POTASSIUM 117 115 29 23
DIGOXIN 116 114 31 59
ESCITALOPRAM OXALATE 114 99 32 99
METOPROLOL SUCCINATE 109 100 33 29
MIRTAZAPINE 107 94 34 51
SERTRALINE HCL 107 79 34 21
PLAVIX 105 97 36 43
LISINOPRIL-HYDROCHLOROTHIAZIDE 104 76 37 27
CARVEDILOL 98 82 38 24
EXELON 98 98 38 117
AMITRIPTYLINE HCL 97 79 R 40 57
CYMBALTA 96 75 41 53
GLYBURIDE 95 75 R 42 46
AMOXICILLIN 92 67 43 119
CLONIDINE HCL 91 46 44 44
SPIRIVA 84 61 45 45
CIPROFLOXACIN HCL 81 71 46 54
LYRICA 78 47 47 72
ALLOPURINOL 76 76 48 33
TRIAMTERENE-HCTZ 75 68 49 48
FLUOXETINE HCL 75 57 49 52
BENAZEPRIL HCL 74 74 51 38
PAROXETINE HCL 73 53 52 55
ALBUTEROL SULFATE 72 72 53 124
QUETIAPINE FUMARATE 72 56 53 70
PROAIR HFA 72 45 53 42
NYSTATIN 70 56 56 132
ROPINIROLE HCL 69 54 57 79
MONTELUKAST SODIUM 67 38 58 162
PREDNISONE 67 65 58 40
ADVAIR DISKUS 66 61 60 63
LOSARTAN-HYDROCHLOROTHIAZIDE 66 52 60 60
NITROGLYCERIN PATCH 64 64 62 177
GEMFIBROZIL 64 39 62 90
CRESTOR 62 51 64 34
AZITHROMYCIN 62 51 64 41
LEVEMIR 61 61 66 145
SPIRONOLACTONE 61 52 66 67
ZETIA 61 52 66 101
GLIMEPIRIDE 60 38 69 31
TERAZOSIN HCL 60 57 69 111
DIOVAN 60 54 69 58
PREMARIN 58 39 R 72 123
VENLAFAXINE HCL ER 58 47 72 102
ISOSORBIDE MONONITRATE ER 58 55 72 66
ALENDRONATE SODIUM 58 55 72 37
TRICOR 57 45 76 125
TRAZODONE HCL 56 27 77 36
JANUVIA 56 44 77 85
DILTIAZEM 24HR CD 52 41 79 95
ABILIFY 51 39 80 178
NOVOLOG 51 43 80 139
LEVOFLOXACIN 50 45 82 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 14, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.